In the last days, an increasing number of COVID-19 cases has been confirmed in various countries around the world, e.g. South Korea and Iran. In the EU extraordinary measures are being taken to limit the outbreak. On 23 February, the ECDC issued a statement on the rapid increase of COVID-19 in Italy. On 24 Febuary, ...
At a time of dramatic news of widespread infections in China from the new corona virus, COVID-19, virologists in the top European institutes are intensively working to understand more about the novel disease.
A so-called ‘productivity crisis’ has been ascribed to the pharmaceutical research and development industry. Despite increases in investment and funding, this has not corresponded to increases in the approval of novel drugs. Why do so many drugs fail to receive approval, and what other means should we be focusing on for the benefit of patients?
The technological revolution involving artificial intelligence, big data, machine learning and robotics is posed to deeply change healthcare and biomedical research, and things are changing fast. In this rapidly evolving scenario, researchers and health professionals need to acquire new skills and knowledge.